Vimarsana
Biggest News Aggregation in the World

Page 14 - Groupa Streptococcus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Groupa Streptococcus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Groupa Streptococcus Today - Breaking & Trending Today

Boy complained of headache before mum raised alarms when his eye went 'puffy' - Vimarsana News

Boy complained of headache before mum raised alarms when his eye went 'puffy'

Carly said her 'world collapsed' as she was told her nine-year-old son had a huge ball of puss on his brain, and would need to have three major surgeries in less than four weeks

Number of iGAS infections surges in Sweden - Vimarsana News

Number of iGAS infections surges in Sweden

STOCKHOLM, Dec. 27 (Xinhua) -- The number of invasive Group A Streptococcus (iGAS) infections, which can be fatal if left untreated, has more than tripled in Sweden this year compared to 2022, local media reported on Wednesday. Read full story ...

Source: wn.com
Number of iGAS infections surges in Sweden - Vimarsana News

Number of iGAS infections surges in Sweden

STOCKHOLM, Dec. 27 (Xinhua) -- The number of invasive Group A Streptococcus (iGAS) infections, which can be fatal if left untreated, has more than tripled in Sweden this year compared to 2022, local media reported on Wednesday.

Research Roundup: Malaria drug for babies, New vaccine initiative, Child-friendly schisto drug - Vimarsana News

Research Roundup: Malaria drug for babies, New vaccine initiative, Child-friendly schisto drug

In today's Research Roundup for December 21, 2023, we highlight some of the most interesting reads in global health research and development from the past week.

Novo Nordisk Foundation Pumps $260M into Vaccines for Respiratory Diseases - Vimarsana News

Novo Nordisk Foundation Pumps $260M into Vaccines for Respiratory Diseases

The new research and vaccine initiative seeks to develop immunizations against influenza, tuberculosis and other deadly respiratory diseases.